Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [1] Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer
    Simoes-Pereira, Joana
    Macedo, Daniel
    Bugalho, Maria Joao
    ENDOCRINE CONNECTIONS, 2016, 5 (06): : 82 - 88
  • [2] Outcomes of patients with bone metastases from differentiated thyroid cancer
    Califano, Ines
    Deutsch, Susana
    Lowenstein, Alicia
    Cabezon, Carmen
    Pitoia, Fabian
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (01): : 14 - 20
  • [3] Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
    Bal, Chandra Sekhar
    Garg, Aayushi
    Chopra, Saurav
    Ballal, Sanjana
    Soundararajan, Ramya
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2015, 28 (7-8) : 745 - 751
  • [4] A retrospective cohort study of patients diagnosed of thyroid cancer in the southwest Madrid area. Predictive factors in differentiated thyroid cancer
    Donnay Candil, Sergio
    Gorgojo Martinez, Juan Jose
    Requejo Salinas, Helena
    Lopez Hernandez, Elena
    Almodovar Ruiz, Francisca
    Mitjavila Casanovas, Mercedes
    Pinedo Moraleda, Fernando
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (02): : 61 - 69
  • [5] LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES
    Hirsch, Dania
    Levy, Sigal
    Tsvetov, Gloria
    Gorshtein, Alexander
    Slutzky-Shraga, Ilana
    Akirov, Amit
    Robenshtok, Eyal
    Shimon, Ilan
    Benbassat, Carlos A.
    ENDOCRINE PRACTICE, 2017, 23 (10) : 1193 - 1200
  • [6] Radiotherapy for Brain Metastases from Thyroid Cancer: An Institutional and National Retrospective Cohort Study
    Blomain, Erik
    Berta, Scott
    Hug, Nicholas
    Giao, Duc
    Meola, Antonio
    Binkley, Michael
    Hui, Caressa
    Churilla, Thomas
    Shahsavari, Nastaran
    Desai, Kaniksha
    Chang, Steven
    Soltys, Scott
    Pollom, Erqi
    THYROID, 2022, 32 (07) : 781 - 788
  • [7] Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study
    Puskulluoglu, Mirosiawa
    Konieczna, Aleksandra
    Swiderska, Katarzyna
    Streb, Joanna
    Pieniazek, Maigorzata
    Grela-Wojewoda, Alek-sandra
    Pacholczak-Madej, Renata
    Mucha-Maiecka, Anna
    Mitus, Jerzy W.
    Szpor, Joanna
    Kunkiel, Michai
    Rudzinska, Agnieszka
    Jarzab, Michai
    Ziobro, Marek
    ACTA ONCOLOGICA, 2024, 63 : 620 - 635
  • [8] Risk of Lymphoma and Leukemia in Thyroid Cancer Patients: A Retrospective Cohort Study in Germany
    Krieg, Andreas
    Krieg, Sarah
    Al Natour, Omar M. S.
    Bruenjes, Stephanie
    Schott, Matthias
    Kostev, Karel
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (08) : 559 - 565
  • [9] Bone metastases in newly diagnosed patients with thyroid cancer: A large population-based cohort study
    Zhang, Ruiguo
    Zhang, Wenxin
    Wu, Cailan
    Jia, Qiang
    Chai, Jinyan
    Meng, Zhaowei
    Zheng, Wei
    Tan, Jian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients
    Raschka, Thore
    Weiss, Sebastian
    Reiter, Alonja
    Barg, Alexej
    Schlickewei, Carsten
    Frosch, Karl-Heinz
    Priemel, Matthias
    JOURNAL OF BONE ONCOLOGY, 2022, 34